LifeMD Inc Preferred Series A
$ 22.35
-1.92%
02 Mar - close price
- Market Cap N/A
- Current Price $ 22.35
- High / Low $ 22.57 / 22.35
- Stock P/E N/A
- Book Value 0.03
- EPS -2.26
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -22.43 %
- 52 Week High 25.00
- 52 Week Low 18.06
About
LifeMD, Inc. is a direct-to-patient telehealth company that connects consumers with healthcare professionals for care in a variety of indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company is headquartered in New York, New York.
Analyst Target Price
N/A
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-17 | 2025-08-05 | 2025-05-06 | 2025-03-11 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 |
| Reported EPS | -0.1 | -0.06 | 0.01 | -0.02 | -0.54 | -0.6402 | -0.4742 | -2.5677 | -1.65 | -0.3655 | -0.23 | -0.071 |
| Estimated EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise | -0.1 | -0.06 | 0.01 | -0.02 | -0.54 | -0.6402 | -0.4742 | -2.5677 | -1.65 | -0.3655 | -0.23 | -0.071 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Jan 2026 | Oct 2025 | Jan 1970 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-01-15 | 2025-10-15 | None | 2025-04-15 | 2025-01-15 | 2024-10-15 | 2024-07-15 | 2024-04-15 | 2024-01-15 | 2023-10-16 |
| Amount | $0.5546875 | $0.5546875 | $0.5546875 | $0.5546875 | $0.5546875 | $0.5546875 | $0.5546875 | $0.5546875 | $0.5546875 | $0.5546875 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LFMDP
2026-03-02 06:52:25
LifeMD (NASDAQ:LFMD) is scheduled to release its Q4 2025 earnings after market close on Monday, March 9, 2026. Analysts anticipate an EPS loss of ($0.01) and revenues of approximately $48.57 million. The stock has experienced significant volatility, with a 52-week range of $2.56 to $15.84, and insider selling has been noted alongside a "Moderate Buy" consensus rating from analysts.
2026-02-27 23:52:05
LifeMD, Inc. (LFMD) is attracting investor attention with a potential upside of 232.73%, driven by its direct-to-patient telehealth model and a diverse portfolio including RexMD, ShapiroMD, and WorkSimpli. Despite a strong revenue growth rate of 13.00% and optimistic analyst ratings, the company faces challenges in achieving profitability and stabilizing valuation metrics. LifeMD is positioned as a compelling opportunity for risk-tolerant investors looking for long-term growth in the expanding telehealth sector.
2026-02-23 23:51:23
LifeMD (Nasdaq: LFMD) is scheduled to report its fourth quarter and full-year 2025 financial results after market close on March 9, 2026. The company will also host a conference call and webcast at 4:30 p.m. Eastern on the same day to discuss the results. The announcement follows a period of mixed stock reactions to recent company news, with positive developments often leading to gains, but a notable decline observed after the preferred dividend announcement.
2026-02-23 12:56:57
LifeMD, Inc. (Nasdaq: LFMD) will release its financial results for the fiscal year and quarter ending December 31, 2025, on March 9, 2026, after U.S. markets close, followed by a conference call at 4:30 p.m. Eastern time. The company, a virtual primary care provider, aims to discuss its performance and continued efforts in accessible healthcare. This announcement includes details on insider trading activity, revenue figures, hedge fund movements, and recent analyst ratings for LFMD.
2026-01-06 09:57:19
LifeMD Inc. surged after announcing it will offer Novo Nordisk's FDA-approved Wegovy pill, the first oral GLP-1 for weight management, through its telehealth platform. This move broadened LifeMD's collaboration with Novo Nordisk and also led to rises in other weight management companies like WW International and GoodRx Holdings, which will also offer the pill at a similar price point. The Wegovy pill was approved by the FDA on December 22, 2025, and showed significant weight loss in clinical trials.
2025-12-09 12:29:56
Jump Financial LLC increased its stake in LifeMD, Inc. (NASDAQ:LFMD) by 205.0% in the second quarter, acquiring an additional 346,171 shares, bringing its total holdings to 515,052 shares valued at $7,015,000. Other institutional investors like Connor Clark & Lunn, Geode Capital Management, and JPMorgan Chase also adjusted their positions in the telehealth company. Despite mixed analyst ratings, with six firms issuing a Buy and one a Hold, the stock has a consensus "Hold" rating and an average target price of $9.25.
